The U.S. Food and Drug Administration on Wednesday approved a low-cost ventilator developed by the University of Minnesota and aimed at helping COVID-19 patients breathe.
The FDA authorized use of the compact device, known as the Coventor, that was quickly developed and designed by a team of university researchers, a medical school resident and an engineer.
The developers hope the Coventor will be used in clinical settings where traditional ventilators are unavailable.
Read Next
CU Boulder to Lift Campus Mask Mandate on Monday
February 28, 2022